Cite
TCT-295 Differential Prognostic Value of Galectin-3 According to Levels of Carbohydrate Antigen 125 in Transcatheter Aortic Valve Implantation.
MLA
Rheude, Tobias, et al. “TCT-295 Differential Prognostic Value of Galectin-3 According to Levels of Carbohydrate Antigen 125 in Transcatheter Aortic Valve Implantation.” Journal of the American College of Cardiology (JACC), vol. 72, no. 13, Sept. 2018, pp. B121–22. EBSCOhost, https://doi.org/10.1016/j.jacc.2018.08.1433.
APA
Rheude, T., Pellegrini, C., Villota, J. N., Trenkwalder, T., Joner, M., Kasel, M., Koenig, W., Bodi, V., Schunkert, H., Kastrati, A., Hengstenberg, C., & Husser, O. (2018). TCT-295 Differential Prognostic Value of Galectin-3 According to Levels of Carbohydrate Antigen 125 in Transcatheter Aortic Valve Implantation. Journal of the American College of Cardiology (JACC), 72(13), B121–B122. https://doi.org/10.1016/j.jacc.2018.08.1433
Chicago
Rheude, Tobias, Costanza Pellegrini, Julio Núñez Villota, Teresa Trenkwalder, Michael Joner, Markus Kasel, Wolfgang Koenig, et al. 2018. “TCT-295 Differential Prognostic Value of Galectin-3 According to Levels of Carbohydrate Antigen 125 in Transcatheter Aortic Valve Implantation.” Journal of the American College of Cardiology (JACC) 72 (13): B121–22. doi:10.1016/j.jacc.2018.08.1433.